To confirm whether the CD4+ T cells were the primary mechanism by which αTim-3 enhanced the anti-tumor immunity of S100, antibody blockade assays were performed, revealing the indispensable role of adaptive immunity for CD4+ T cells in the combination of αTim-3 with S100. Here, CD4 is linked to neoplasm.